Differential transmyocardial platelet behavior in response to pacing and ergonovine-induced myocardial ischemia

Am Heart J. 1986 Aug;112(2):255-62. doi: 10.1016/0002-8703(86)90259-0.

Abstract

In 17 anginal patients with critical narrowing of the left anterior descending artery, we studied the effects of acute ischemia, either induced by atrial pacing or by ergonovine, on transmyocardial platelet behavior. Six other patients with atypical chest pain and normal coronary arteries served as controls. Simultaneous arterial and great cardiac vein samples were drawn during control and ischemia to measure the levels of platelet factor four (PF4) and beta-thromboglobulin (BTG). During pacing-induced ischemia the great cardiac vein-arterial differences of PF4 and BTG decreased significantly, indicating a reduced platelet aggregability; no significant changes were observed in the control patients. By contrast, when ischemia resulted from ergonovine-induced spasm of the left anterior descending artery (five patients), the great cardiac vein-arterial differences increased, indicating enhanced platelet aggregability. Again no differences were observed in the patients with a negative ergonovine test. The results of our study suggest that the transcardiac platelet behavior may vary during different ischemic conditions. When ischemia is due to increased myocardial demands and flow is normal or increased, myocardial metabolites released from the ischemic area may oppose platelet aggregation. By contrast, spasm and the stagnant flow resulting from it may enhance platelet aggregation.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Angina Pectoris / blood*
  • Angina Pectoris / diagnosis
  • Blood Platelets / metabolism
  • Cardiac Pacing, Artificial*
  • Coronary Disease / blood*
  • Coronary Disease / etiology
  • Coronary Vessels / drug effects
  • Ergonovine / analogs & derivatives*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardium / metabolism
  • Platelet Aggregation*
  • Platelet Count
  • Platelet Factor 4 / analysis
  • beta-Thromboglobulin / analysis

Substances

  • beta-Thromboglobulin
  • Platelet Factor 4
  • Ergonovine